欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/0695/001
药品名称Ciprofloxacine Kabi 100 mg/50 ml, oplossing voor intraveneuze infusie 2 mg/ml
活性成分
    • ciprofloxacin 2.0 mg/ml
剂型Solution for infusion
上市许可持有人Fresenius Kabi Nederland B.V. Amersfoortseweg 10E 3705 GJ Zeist
参考成员国 - 产品名称Netherlands (NL)
互认成员国 - 产品名称
    • Slovakia (SK)
    • Denmark (DK)
    • Belgium (BE)
    • Spain (ES)
    • Sweden (SE)
    • Finland (FI)
    • Hungary (HU)
    • Germany (DE)
    • United Kingdom (Northern Ireland) (XI)
    • Austria (AT)
      Ciprofloxacin Kabi 100/50 ml Infusionslösung
    • Portugal (PT)
    • Italy (IT)
    • Poland (PL)
      Ciproflaxacin Kabi 100 mg/50 ml
许可日期2007/01/24
最近更新日期2024/06/03
药物ATC编码
    • J01MA02 ciprofloxacin
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic [Article 10.1.(a)(iii), first paragraph]
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase